VR Adviser as of June 30, 2021
Portfolio Holdings for VR Adviser
VR Adviser holds 29 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Instil Bio | 16.1 | $133M | 6.9M | 19.32 | |
| Aclaris Therapeutics (ACRS) | 9.7 | $80M | 4.6M | 17.56 | |
| Vistagen Therapeutics | 6.1 | $51M | 16M | 3.15 | |
| Graphite Bio | 6.0 | $50M | 1.6M | 30.73 | |
| Marinus Pharmaceuticals (MRNS) | 5.7 | $47M | 2.6M | 17.94 | |
| Relmada Therapeutics (RLMD) | 5.4 | $44M | 1.4M | 32.01 | |
| Olema Pharmaceuticals (OLMA) | 5.2 | $43M | 1.5M | 27.98 | |
| Celldex Therapeutics (CLDX) | 5.0 | $42M | 1.2M | 33.44 | |
| Altimmune (ALT) | 4.2 | $35M | 3.5M | 9.85 | |
| Kinnate Biopharma (KNTE) | 4.2 | $34M | 1.5M | 23.28 | |
| Gh Research Ord Sh (GHRS) | 3.4 | $28M | 1.3M | 21.73 | |
| Cullinan Oncology (CGEM) | 3.0 | $25M | 976k | 25.75 | |
| Centessa Pharmaceuticals Spons Ads (CNTA) | 3.0 | $25M | 1.1M | 22.21 | |
| Provention Bio | 3.0 | $25M | 2.9M | 8.43 | |
| Trillium Therapeutics, Inc. Cmn | 2.4 | $19M | 2.0M | 9.70 | |
| Essa Pharma (EPIX) | 2.2 | $18M | 626k | 28.57 | |
| CVRX (CVRX) | 2.2 | $18M | 633k | 28.00 | |
| Pharvaris N V (PHVS) | 2.0 | $17M | 903k | 18.63 | |
| Athira Pharma (ATHA) | 1.8 | $15M | 1.5M | 10.24 | |
| Rapt Therapeutics (RAPT) | 1.5 | $12M | 391k | 31.79 | |
| Kura Oncology (KURA) | 1.5 | $12M | 575k | 20.85 | |
| Keros Therapeutics (KROS) | 1.4 | $12M | 272k | 42.47 | |
| Cogent Biosciences (COGT) | 1.1 | $8.8M | 1.1M | 8.11 | |
| Aligos Therapeutics (ALGS) | 1.0 | $8.3M | 408k | 20.39 | |
| Akoya Biosciences (AKYA) | 0.9 | $7.7M | 400k | 19.34 | |
| Harpoon Therapeutics | 0.9 | $7.1M | 512k | 13.87 | |
| Catabasis Pharmaceuticals Ord | 0.8 | $6.8M | 3.2M | 2.11 | |
| Adicet Bio (ACET) | 0.2 | $1.9M | 184k | 10.29 | |
| Miragen Therapeutics (VRDN) | 0.0 | $357k | 20k | 18.31 |
